Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial

Yunpeng Yang(Sun Yat-sen University), Wenfeng Fang(Sun Yat-sen University), Jianying Zhou(First Affiliated Hospital Zhejiang University), Ying Cheng(Jilin Province Tumor Hospital), Manxiang Li(First Affiliated Hospital of Guangzhou Medical University), Xintian Qin(First Affiliated Hospital of Guangdong Pharmaceutical University), Nong Yang(Central South University), Hong Chen(Chongqing University), Li Zhang(Gdańsk Medical University), Jifeng Feng(Zhejiang Cancer Hospital), Jianxing He(First Affiliated Hospital of Guangzhou Medical University), Jiän Zhang(Qingdao University), Jie Min(Air Force Medical University), Wu Zhuang(Hunan University), Yan Yu(Binzhou Medical University), Shou’an Ren(Shanxi Medical University), Lejie Cao(University of Science and Technology of China), Qitao Yu(Tumor Hospital of Guangxi Medical University), Hao Yu(China National GeneBank), Yanqiu Zhao(Henan Cancer Hospital)
Signal Transduction and Targeted Therapy
August 14, 2023
10.1038/s41392-023-01538-w
Cited by 32

Related Papers

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2019|3.4k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2017|1.2k
Comparative genomics reveals insights into avian genome evolution and adaptation
|Science|2014|1.2k